Ohio
Retatrutide
Buy Retatrutide in Ohio: Triple-Action Weight Loss
Ohio residents can access the most advanced weight loss medication through TRIMI.
Last updated: April 1, 2026•8 min read
Retatrutide targets GLP-1, GIP, and glucagon receptors for up to 24% body weight loss. Ohio residents can access this triple-action medication through TRIMI telehealth -- from Columbus to Cleveland, Cincinnati to rural Appalachia.
Triple-Action
GLP-1
Appetite suppression.
GIP
Insulin sensitivity.
Glucagon
Fat burning.
Comparison
| Med | Receptors | Loss |
|---|---|---|
| Semaglutide | 1 | 15-17% |
| Tirzepatide | 2 | 20-22% |
| Retatrutide | 3 | Up to 24% |
Ohio Access
- • Telehealth statewide
- • 3-7 day delivery
- • All Ohio cities and rural areas
- • Licensed compounding
Getting Started
- Online health assessment
- Virtual OH-licensed provider visit
- Custom retatrutide protocol
- Home delivery
Medical Disclaimer
Informational only. Retatrutide is investigational. Requires provider evaluation. Side effects may occur.
More on state guides
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).